anpac_logo_full color_stacked.png
AnPac Bio Reports Fiscal Year 2021 Annual Financial Results
May 16, 2022 17:00 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 16, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Asia Breast Cancer Screening Market Report 2022: Market is Expected to Reach $16.5 Billion by 2027 from $10.1 Billion in 2021, Post Recovery from the Pandemic
May 04, 2022 04:13 ET | Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Breast Cancer Screening Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis" report has been...
22157.jpg
Global Diagnostic Specialty Antibodies Market to 2029 - by Type, Clonality, Technique, Conjugate and Application
April 26, 2022 06:13 ET | Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Diagnostic Specialty Antibodies Market by Type, Clonality, Technique, Conjugate, and Application - Forecast to 2029" report has been added to...
anpac_logo_full color_stacked.png
AnPac Bio and New Investor Sign Equity Investment Totaling $15 Million
April 11, 2022 07:30 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
TIP_link_300x300.jpg
Liver Cancer Diagnostics Market Worth $15.95Bn, Globally, by 2028 at 8% CAGR - Exclusive Report by The Insight Partners
April 07, 2022 10:50 ET | The Insight Partners
New York, April 07, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
22157.jpg
Asia-Pacific Cancer Screening Market Outlook Report 2022: Growing Advancements in the Field of Healthcare Technologies are Anticipated to Drive Market Growth
March 24, 2022 06:48 ET | Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cancer Screening Market Outlook 2020-2030" report has been added to ResearchAndMarkets.com's offering. The Asia Pacific cancer screening...
Global Circulating Tumor Cell (CTC) Diagnostics Technologies and Markets 2022-2026 Featuring Qiagen, Biocept, Greiner Bio One, Precision Medicine Group and Menarini Silicon Biosystems
March 11, 2022 04:58 ET | Research and Markets
Dublin, March 11, 2022 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The scope of...
anpac_logo_full color_stacked.png
AnPac Bio’s Bio-Chip Subsidiary, Changwei System Technology Co., Ltd., Receives Independent Valuation and Approval from the Board to Explore Strategic Alternatives
March 03, 2022 07:00 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, March 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
For Colorectal Cancer Awareness Month, the Colon Cancer Coalition invites Americans to join the most important mission on Earth: #MissionToUranus.
February 28, 2022 10:00 ET | Colon Cancer Coalition
Minneapolis, Dallas, Miami & NYC, Feb. 28, 2022 (GLOBE NEWSWIRE) -- In recognition of Colorectal Cancer Awareness Month, Colon Cancer Coalition and cross-cultural agency BeautifulBeast invite...
anpac_logo_full color_stacked.png
AnPac Bio Files CDA Device for Breakthrough Medical Device Designation Request with the FDA
February 03, 2022 07:30 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Feb. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...